FGF23 and cardiac hypertrophy: Enhanced FGF23 levels are associated with the development of LVH in patients with CKD (Kovesdy and Quarles, 2016) and it has been shown that FGF23 directly induces cardiac hypertrophy in vitro and in vivo (Faul et al., 2011).